1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Weight Loss

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Weight Loss in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
At Muhammed, R; El-Medany, A; El-Medany, G; El-Rakhawy, FI; Hagar, HH; Moursi, M	1
Castellino, P; DeFronzo, RA; Tuttle, KR	1

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Weight Loss

Article	Year
Attenuation of bleomycin-induced lung fibrosis in rats by mesna. European journal of pharmacology, 2005, Feb-10, Volume: 509, Issue:1 Topics: Animals; Bleomycin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Glutathione; Hydroxyproline; Injections, Intraperitoneal; Lung; Male; Mesna; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Peroxidase; Platelet Activating Factor; Pulmonary Fibrosis; Rats; Rats, Wistar; Time Factors; Tumor Necrosis Factor-alpha; Weight Gain; Weight Loss	2005
Diabetic nephropathy. Current therapy in endocrinology and metabolism, 1994, Volume: 5 Topics: Adrenergic beta-Antagonists; Aldehyde Reductase; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet, Protein-Restricted; Diuretics; Exercise; Glycosylation; Guanidines; Humans; Hypertension; Platelet Activating Factor; Rats; Somatostatin; Weight Loss	1994

Article

Year

Attenuation of bleomycin-induced lung fibrosis in rats by mesna.

European journal of pharmacology, 2005, Feb-10, Volume: 509, Issue:1

Topics: Animals; Bleomycin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Glutathione; Hydroxyproline; Injections, Intraperitoneal; Lung; Male; Mesna; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Peroxidase; Platelet Activating Factor; Pulmonary Fibrosis; Rats; Rats, Wistar; Time Factors; Tumor Necrosis Factor-alpha; Weight Gain; Weight Loss

2005

Diabetic nephropathy.

Current therapy in endocrinology and metabolism, 1994, Volume: 5

Topics: Adrenergic beta-Antagonists; Aldehyde Reductase; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet, Protein-Restricted; Diuretics; Exercise; Glycosylation; Guanidines; Humans; Hypertension; Platelet Activating Factor; Rats; Somatostatin; Weight Loss

1994